AFP and neoplasm: Currently, the uptake of contrast agent in the arterial phase of dynamic CT or MRI, is the reference method to assess the persistence of viable tumor in the lesion [2,12], while serum biomarkers, such as AFP and PIVKA-II, can integrate the evaluation [14,15,16,17].